• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • About Us
  • Contact Us
  • Billing Portal
SPRINT® PNS System

SPR Therapeutics

SPRINT PNS System

  • Product
  • For Physicians
    • Clinical Outcomes & References
    • Implant Procedure Videos
    • Video Resources
    • SPRcare Reimbursement
    • Important Safety Information
    • MRI Safety Information
    • Promotional Marketing Toolkit
  • For Patients
    • Patient Stories
    • Patient Resources
    • Recursos para pacientes
    • MicroLead™ Safety
    • MRI Safety Information
  • Clinical Trials
  • News & Events
    • News
    • Events
    • Press Room
  • Careers

Dr. Samir Sheth discusses how the SPRINT® PNS System has impacted his approach to treating patients with chronic head and neck pain

January 17, 2023

Just over one year ago, the SPRINT PNS System received an expanded indication enabling the on-label treatment of chronic head and neck pain. Board-certified anesthesiologist, interventional pain specialist and SPR consultant Dr. Samir Sheth shares how he got started with the SPRINT PNS System and his experiences with PNS of the occipital and cervical medial branch nerves.

What were your early experiences with the SPRINT PNS System?

Early on, I had been really interested in neuromodulation, and a little less so with peripheral nerve stimulation. Then about three years ago, a 35-year-old patient with multiple sclerosis and chronic low back pain came into my office. I just didn’t feel comfortable doing a radiofrequency ablation (RFA) of her lumbar spine. Because the SPRINT PNS System is low risk, I thought it made sense to try. 

The patient did really well with the treatment. Since then, I’ve done around 200 SPRINT PNS cases on everything from shoulders and back to knees. It became something I consider very early in my treatment algorithm. In my experience, SPRINT PNS is a  non-destructive and low-risk, potentially high-reward option for many patients.

What makes the SPRINT PNS System appealing for the treatment of head and neck pain?

Head and neck pain can be debilitating—many of my patients have a severely impacted quality of life. It can be so difficult to treat. Many are affected by the pain in their sleep, in their work, in their day-to-day routines. So, if they can experience even a little bit of relief, it’s a really a big deal.

Prior to SPRINT PNS, I had success using traditional spinal cord stimulation (SCS) systems to stimulate the occipital nerve, but I couldn’t always get approval or authorization for those cases. In addition, my experience with SCS systems targeting the occipital nerve is that they were tedious and had issues with lead migration and lead erosion. I was also doing nerve blocks and RFA. Now, I prefer to present SPRINT PNS earlier in my care continuum, before SCS and RFA, as the risks are low, and the benefits can be significant. If I can potentially get sustained pain relief with a non-destructive device like SPRINT PNS, why wouldn’t I consider that first? Obtaining sustained pain relief with a non-destructive device like SPRINT PNS provides clinicians with a new powerful option for our patients.

Tell us about your experience using SPRINT PNS in chronic head and neck pain.

So far, I’ve done 15-20 of these cases, and I’ve been very impressed with the amount of relief patients are experiencing. Many of my patients with occipital nerve stimulation have done so well—describing significant pain relief, and their medication use is down to almost zero. For me, that’s a significant win that we often do not discuss, because of the potential impact of chronic use of NSAIDs and migraine medications on their bodies.

At what point would you recommend considering the use of the SPRINT PNS System for patients who experience chronic pain in the head and neck area?

For many of my patients, this is one of the first options I like to discuss with them. I like presenting a minimally-invasive treatment like the SPRINT PNS System over RFA for my patients. It’s important to let patients know that they have a non-destructive, non-permanent, non-surgical treatment option. 

With serious adverse events being rare and infections occurring less than 1% of the time, the safety profile is another reason I like to present this option.  The most common adverse event is skin irritation from the adhesive components, with other less-reported events including itching at the electrode exit site, granuloma, and pain after electrode placement.

Ultimately, in patients who have significant pain in the back of their head or neck, there are very few reasons not to consider the SPRINT PNS System early in the care continuum—I’ve been very impressed with the relief I’ve seen so far, and I am very excited to have treatment opportunities to increase therapy awareness for this debilitating condition.

Visit SprintPNS.com to view implant videos, clinical outcomes and references. Or call 844.378.9108 to learn how your practice can outsmart head and neck pain.


The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. 

Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.  

Important safety & risk information: https://bit.ly/2FU92NH


Share this post:

Share on Twitter Share on Facebook Share on LinkedIn Share on SMS Share on Email
Category: News
Previous Post:SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
Next Post:SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sidebar

Archives

Recent News

SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Dr. Samir Sheth discusses how the SPRINT® PNS System has impacted his approach to treating patients with chronic head and neck pain

SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022

A Discussion on Pain Management Options for Patients with Breast Cancer with Dr. Amitabh Gulati

Real-World Retrospective Review of Axial Neck Pain Relief Following Peripheral Nerve Stimulation of Cervical Medial Branch Nerves

Tags

60-day percutaneous PNS acute pain Back Pain back pain treatment cancer pain chronic back pain Chronic Pain clinical study Dr. Mehul Desai drug-free EY award hip pain low back pain medial branch Neuromodulation Non-opioid oncological pain opioid alternative Pain pain appointment pain physician pain relief pain treatment Patients Patient Story peripheral nerve stimulation permanent PNS implant phantom limb pain PNS PNS training post-amputation pain Press release radiofrequency ablation recondition CNS reduced opioids research Research study residual limb pain RFA Shoulder Pain SPRINT PNS SPRINT PNS System temporary pns Training lab webinar
SPRINT® PNS System

22901 Millcreek Blvd, Suite 500
Cleveland, OH 44122
(844) 378-9108 Phone
(216) 803-0777 Fax

Top Work Places 2022

Quick Links

  • Product
  • For Physicians
  • For Patients
  • Clinical Trials
  • News & Events
  • Careers
  • About Us
  • Contact Us

Legal Links

  • Privacy Statement
  • Terms of Use
  • CPRA Requests
  • Important Safety Information
  • Compliance
  • FCOI Policy
  • Product Terms & Conditions
  • Patent Information

Recent News Headlines

SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System

Sprint Regional Lab Fluoro Only – Boston

Sprint Regional Lab – Boston

SPRINT PNS Regional Lab & APP Program: Kansas City

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to be placed in the region innervated by the cranial and facial nerves. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View References for support of all claims.

The SPRINT® PNS System, MicroLead™, OnePass Introducer™, Rethink Your Pain Strategy™, Outsmart Pain™, Sustained Pain Relief Starts Here™, Life. Get Back to It.™ and SPR® are registered or common law trademarks of SPR Therapeutics, Inc.


Copyright © 2023 SPR Therapeutics. All Rights Reserved.

This website is intended only for US and Canadian residents 18 years of age and older. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo